sulfamic acid has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diercks, BP; Dohle, W; Flügel, A; Flügel, LT; Guse, AH; Hosang, L; Löhndorf, A; Marry, S; Müller-Kirschbaum, LC; Odoardi, F; Potter, BVL; Rosche, A | 1 |
| Barenholz, Y; Garbuzenko, O; Kizelsztein, P; Ovadia, H; Sigal, A | 1 |
2 other study(ies) available for sulfamic acid and Allergic Encephalomyelitis
| Article | Year |
|---|---|
2-Methoxyestradiol-3,17-O,O-bis-sulfamate inhibits store-operated Ca
Topics: 2-Methoxyestradiol; Animals; Encephalomyelitis, Autoimmune, Experimental; Pharmaceutical Preparations; Rats; Rats, Inbred Lew; T-Lymphocytes | 2023 |
Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis.
Topics: Animals; Antioxidants; Blood-Brain Barrier; Brain; Cyclic N-Oxides; Diffusion; Disease Models, Animal; Drug Delivery Systems; Encephalomyelitis, Autoimmune, Experimental; Female; Liposomes; Mice; Nanocapsules; Oxidative Stress; Polyethylene Glycols; Reactive Oxygen Species; Sulfonic Acids; Treatment Outcome | 2009 |